Frontiers in Hematology is a peer-reviewed english-language open-access journal published by Frontiers Media S.A. in Switzerland, operating under an open-access model since 2022. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Frontiers in Hematology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Frontiers in Hematology has published 185 articles. Articles are minted with DOIs through the prefix 10.3389. All submissions undergo plagiarism screening before peer review.
Keywords
hematology, haematological tumours, genetic immunology, stem cells, cancer therapy
At a glance
- Publisher
- Frontiers Media S.A.
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2022
- Review time
- 15 weeks
- DOI prefix
10.3389- Plagiarism check
- Yes
ISSN
- electronic
- 2813-3935
Frequently asked questions
Is Frontiers in Hematology peer-reviewed?
Does Frontiers in Hematology charge an article processing charge (APC)?
What subjects does Frontiers in Hematology publish?
What languages does Frontiers in Hematology accept?
What is the ISSN of Frontiers in Hematology?
2813-3935 (electronic).